未名醫藥(002581.SZ):簽署山東未名生物醫藥產業園投資建設和資產回購協議
格隆匯8月16日丨未名醫藥(002581.SZ)公佈,公司於2023年8月14日召開了第五屆戰略委員會第二次會議、第五屆董事會第十七次會議、第五屆監事會第十一次會議,審議通過了《關於簽署<山東未名生物醫藥產業園投資建設和資產回購協議>暨接受關聯方擔保的議案》。
此前披露,公司與淄博市張店區工業和信息化局簽署《行政服務協議》,在淄博市張店經濟開發區合作建設山東未名生物醫藥產業園。
根據《行政服務協議》相關約定,為順利推進各方合作建設山東未名生物醫藥產業園,公司擬與山東齊贏產業投資發展有限公司(簡稱“山東齊贏”)、山東聚泰產業發展有限公司(簡稱“山東聚泰”)、公司董事長岳家霖先生共同簽署《山東未名生物醫藥產業園投資建設和資產回購協議》。
由山東齊贏、山東聚泰負責墊資山東未名生物醫藥產業園一期規劃設計、徵地和廠房、辦公樓、附屬設施建設等,公司已確認同意產業園一期規劃設計方案。山東聚泰系山東齊贏全資子公司,公司、山東齊贏、山東聚泰確認,由山東齊贏委託山東聚泰具體開展項目一期徵地、立項、設計、建設等工作。
建設範圍為山東未名生物醫藥產業園一期項目位於興園路以南、興園南路以北,解營路以西、崛起路以東,主要為廠房、辦公樓及相關配套等建設。建設內容、建設標準由各方以書面形式另行確定。
回購時間為2028年底前。回購範圍為山東未名生物醫藥產業園一期資產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.